- Report
- June 2025
Global
From €4321EUR$4,900USD£3,741GBP
- Report
- July 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1764EUR$2,000USD£1,527GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1764EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1764EUR$2,000USD£1,527GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1764EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1323EUR$1,500USD£1,145GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1323EUR$1,500USD£1,145GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1102EUR$1,250USD£954GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1102EUR$1,250USD£954GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1102EUR$1,250USD£954GBP
- Report
- May 2025
- 150 Pages
Global
From €2645EUR$2,999USD£2,290GBP
- Report
- September 2025
- 374 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 274 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 395 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 384 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 383 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 898 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 363 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1764EUR$2,000USD£1,527GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more